Key Financial Data Of Reporting Company

D.Western Therapeutics Institute, Inc. - Filing #7612941

Concept 2021-01-01 to
2021-12-31
As at
2021-12-31
As at
2021-12-31
2021-01-01 to
2021-12-31
2020-01-01 to
2020-12-31
As at
2020-12-31
2020-01-01 to
2020-12-31
As at
2020-12-31
As at
2019-12-31
2019-01-01 to
2019-12-31
2019-01-01 to
2019-12-31
As at
2019-12-31
As at
2018-12-31
As at
2018-12-31
2018-01-01 to
2018-12-31
2018-01-01 to
2018-12-31
2017-01-01 to
2017-12-31
2017-01-01 to
2017-12-31
As at
2017-12-31
As at
2017-12-31
Key financial data of reporting company
Business results of reporting company
Net sales
412,121,000 JPY
414,424,000 JPY
355,586,000 JPY
334,522,000 JPY
580,527,000 JPY
549,024,000 JPY
292,924,000 JPY
289,431,000 JPY
245,673,000 JPY
254,028,000 JPY
Ordinary profit (loss)
-39,043,000 JPY
-159,711,000 JPY
-289,527,000 JPY
-200,950,000 JPY
109,578,000 JPY
172,648,000 JPY
-796,906,000 JPY
-666,281,000 JPY
-557,934,000 JPY
-668,904,000 JPY
Profit (loss)
-240,741,000 JPY
-201,927,000 JPY
171,671,000 JPY
-970,380,000 JPY
-1,496,103,000 JPY
Share capital
573,159,000 JPY
556,856,000 JPY
34,762,000 JPY
34,762,000 JPY
3,365,279,000 JPY
Total number of issued shares
29,358,600 xbrli:shares
29,251,100 xbrli:shares
26,275,200 xbrli:shares
26,275,200 xbrli:shares
26,258,400 xbrli:shares
Net assets
2,006,974,000 JPY
2,035,138,000 JPY
2,215,176,000 JPY
2,163,905,000 JPY
1,408,083,000 JPY
1,370,158,000 JPY
1,198,486,000 JPY
1,300,101,000 JPY
2,095,869,000 JPY
2,160,999,000 JPY
Total assets
2,427,279,000 JPY
2,462,860,000 JPY
2,780,756,000 JPY
2,737,711,000 JPY
1,981,349,000 JPY
1,932,252,000 JPY
1,965,276,000 JPY
2,073,753,000 JPY
2,877,489,000 JPY
2,935,773,000 JPY
Net assets per share
68.27
68.27
75.64
73.88
53.02
52.15
45.61
47.95
76.14
82.23
Dividend paid per share
Interim dividend paid per share
Basic earnings (loss) per share
-8.21
-5.08
-10.16
-7.43
5.07
6.53
-28.51
-36.94
-57.31
-59.89
Diluted earnings per share
Equity-to-asset ratio
0.826 xbrli:pure
0.814 xbrli:pure
0.796 xbrli:pure
0.789 xbrli:pure
0.703 xbrli:pure
0.709 xbrli:pure
0.610 xbrli:pure
0.608 xbrli:pure
0.695 xbrli:pure
0.736 xbrli:pure
Rate of return on equity
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
0.100 xbrli:pure
0.134 xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
Price-earnings ratio
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
128.0 xbrli:pure
99.4 xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
Payout ratio
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
Net cash provided by (used in) operating activities
-176,306,000 JPY
-216,284,000 JPY
175,651,000 JPY
-540,333,000 JPY
-797,215,000 JPY
Net cash provided by (used in) investing activities
-111,150,000 JPY
-13,465,000 JPY
-100,000,000 JPY
-7,775,000 JPY
-763,123,000 JPY
Net cash provided by (used in) financing activities
-104,459,000 JPY
1,004,126,000 JPY
-120,000,000 JPY
JPY
1,406,969,000 JPY
Cash and cash equivalents
1,933,743,000 JPY
2,308,210,000 JPY
1,540,784,000 JPY
1,584,282,000 JPY
2,132,677,000 JPY
Number of employees
16 xbrli:pure
19 xbrli:pure
13 xbrli:pure
15 xbrli:pure
17 xbrli:pure
14 xbrli:pure
14 xbrli:pure
17 xbrli:pure
15 xbrli:pure
14 xbrli:pure
Average number of temporary employees
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
Total shareholder return
0.529 xbrli:pure
0.708 xbrli:pure
1.591 xbrli:pure
1.407 xbrli:pure
1.255 xbrli:pure
Total return on share price index
1.469 xbrli:pure
1.303 xbrli:pure
1.213 xbrli:pure
1.027 xbrli:pure
1.222 xbrli:pure

Talk to a Data Expert

Have a question? We'll get back to you promptly.